Dishman Pharmaceuticals and Chemicals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 17, 2015, inter alia, to consider and take on record the Audited Financial Results of the Company for the year ended March 31, 2015 and to recommend Final Dividend, if any.<BR><BR>In view of the same, the trading window for the Designated Persons of the Company shall remain close from July 11, 2015 to July 19, 2015 (both days inclusive). During this period, Directors, Designated Persons and their dependents are required not to deal in the shares of the Company.
|